Quick Answer
NEPHROS INC reported Diluted EPS of $0.11 per share for fiscal year 2025.
NEPHROS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.11 | +1000.0% |
| 2024 | $0.01 | +106.7% |
| 2023 | -$0.15 | +79.5% |
| 2022 | -$0.73 | -135.5% |
| 2014 | -$0.31 | -72.2% |
| 2013 | -$0.18 | -109.7% |
| 2010 | $1.86 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.03 | +50.0% | +50.0% |
| June 30, 2025 | $0.02 | +166.7% | -60.0% |
| March 31, 2025 | $0.05 | +350.0% | +150.0% |
| September 30, 2024 | $0.02 | +200.0% | +166.7% |
| June 30, 2024 | -$0.03 | +25.0% | -50.0% |
| March 31, 2024 | -$0.02 | +33.3% | +0.0% |
| September 30, 2023 | -$0.02 | +93.5% | +50.0% |
| June 30, 2023 | -$0.04 | +66.7% | -33.3% |
- NEPHROS INC showed an increase of +1000.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2025 period, NEPHROS INC’s diluted eps has declined by 94.1% (from $1.86 per share to $0.11 per share).
- The most recent figure is from NEPHROS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: